Video Center


The OBR Video Center Features educational videos covering a wide range of oncology specific topics.

William K. Oh, MD, summarizes outcomes from the ACIS study as presented at ASCO GU 2021

Dr. Oh, Clinical Professor of Medicine, Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, provides a summary of the ACIS study evaluating the combination of apalutamide and abiraterone plus prednisone (AAP) versus abiraterone plus prednisone in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC)

Tags: ASCO GU Conference CoverageProstate

Published: 23 February 2021

Recent Videos

video

Eleni Efstathiou, MD, PhD, regarding the PROSPER clinical trial from ASCO GU 2021

Dr. Efstathiou, Associate Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer ...

video

Eleni Efstathiou, MD, PhD, offers opinion on the ACIS clinical trial

Dr. Efstathiou, Associate Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer ...

video

Eleni Efstathiou, MD, PhD, elaborates on the role of chemotherapy in mCRPC

Dr. Efstathiou, Associate Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer ...

video

Eleni Efstathiou, MD, PhD, discusses the prostate-specific membrane antigen (PSMA) lutetium

Dr. Efstathiou, Associate Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer ...

video

Eleni Efstathiou, MD, PhD, considers the role of precision medicine in prostate cancer

Dr. Efstathiou, Associate Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer ...

video

Eleni Efstathiou, MD, PhD, regarding the preliminary analysis of belzutifan & cabozantinib in ccRCC

Dr. Efstathiou, Associate Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer ...

video

Eleni Efstathiou, MD, PhD, offers a message for patients on clinical progress in prostate cancer

Dr. Efstathiou, Associate Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer ...

video

Matthew Galsky, MD, shares a message for patients regarding clinical progress in bladder cancer

Dr. Galsky, Acting Chief, Division of Hematology and Medical Oncology, Mount Sinai Health System, Director of Genitourinary Medical Oncology, Co-Director, ...

video

Matthew Galsky, MD, on the role of PD-L1 testing in previously untreated, locally advanced or mUC

Dr. Galsky, Acting Chief, Division of Hematology and Medical Oncology, Mount Sinai Health System, Director of Genitourinary Medical Oncology, Co-Director, ...

video

Matthew Galsky, MD, elaborates on outcomes from the CheckMate 274 trial

Dr. Galsky, Acting Chief, Division of Hematology and Medical Oncology, Mount Sinai Health System, Director of Genitourinary Medical Oncology, Co-Director, ...

Related Videos

video-image

Eleni Efstathiou, MD, PhD, offers a message for patients on clinical progress in prostate cancer

video-image

Eleni Efstathiou, MD, PhD, regarding the preliminary analysis of belzutifan & cabozantinib in ccRCC

video-image

Eleni Efstathiou, MD, PhD, considers the role of precision medicine in prostate cancer

video-image

Eleni Efstathiou, MD, PhD, discusses the prostate-specific membrane antigen (PSMA) lutetium

video-image

Eleni Efstathiou, MD, PhD, elaborates on the role of chemotherapy in mCRPC

video-image

Eleni Efstathiou, MD, PhD, offers opinion on the ACIS clinical trial

video-image

Eleni Efstathiou, MD, PhD, regarding the PROSPER clinical trial from ASCO GU 2021

video-image

Sumanta K. Pal, MD, shares thoughts on the TIVO-3 trial from ASCO GU 2021

video-image

Matthew Galsky, MD, shares a message for patients regarding clinical progress in bladder cancer

video-image

William K. Oh, MD, on the real-world analysis of abiraterone & docetaxel in mHSPC

video-image

Sumanta K. Pal, MD, offers a message to patients regarding clinical progress in kidney cancer

video-image

Sumanta K. Pal, MD, elaborates on the design and outcomes of the PAPMET trial from ASCO GU 2021

video-image

Jorge A. Garcia, MD, discusses highlights from the final analysis of the TITAN study

video-image

William K. Oh, MD, offers opinion on the role of chemotherapy in the treatment of mCRPC

video-image

Jorge A. Garcia, MD, elaborates on the role of PARP inhibitors in the treatment of mCRPC

video-image

Sumanta K. Pal, MD, considers the unmet needs in the treatment of papillary RCC

video-image

Jorge A. Garcia, MD, offers opinion on the role of chemotherapy in the treatment of mCRPC

video-image

William K. Oh, MD, offers opinion on the final analysis of the TITAN study

video-image

Jorge A. Garcia, MD, on the real-world analysis of abiraterone acetate & docetaxel in mHSPC

video-image

Sumanta K. Pal, MD, regarding the quality of life outcomes from CheckMate 9ER